26 related articles for article (PubMed ID: 23999647)
1. Antigen-specificity of oligoclonal abnormal protein bands in multiple myeloma after allogeneic stem cell transplantation.
Rahlff J; Trusch M; Haag F; Bacher U; Horst A; Schlüter H; Binder M
Cancer Immunol Immunother; 2012 Oct; 61(10):1639-51. PubMed ID: 22350072
[TBL] [Abstract][Full Text] [Related]
2. Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma.
Carlisi M; Presti RL; Plano F; Mancuso S; Siragusa S; Caimi G
Sci Rep; 2024 Feb; 14(1):2832. PubMed ID: 38310176
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of unexpected protein bands in multiple myeloma patients after autologous stem cell transplantation.
Kim SK; Jeong TD; Kim SY; Lee W; Chun S; Suh CW; Min WK
Clin Biochem; 2014 May; 47(7-8):588-92. PubMed ID: 24582697
[TBL] [Abstract][Full Text] [Related]
4. Application of oligoclonal bands and other cerebrospinal fluid variables in multiple sclerosis and other neuroimmunological diseases: a narrative review.
Jin H; Lu Q; Gao F; Hao H
Ann Transl Med; 2023 Apr; 11(7):282. PubMed ID: 37090049
[TBL] [Abstract][Full Text] [Related]
5. Emergence of Oligoclonal Bands in Association with the use of Chemotherapy and Hematopoietic Stem Cell Transplantation.
Paul C; Chakraborty S; Chakraborty S
Indian J Clin Biochem; 2022 Jul; 37(3):328-334. PubMed ID: 35873608
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma.
Liang Z; Li P; Kang L; Zhou L; Xu Y; Ye S; Du J; Li B; Wang Y; Yu L; Qian W; Liang A
Blood Adv; 2022 Jan; 6(1):293-296. PubMed ID: 34758063
[No Abstract] [Full Text] [Related]
7. Treatment Strategy for Multiple Myeloma to Improve Immunological Environment and Maintain MRD Negativity.
Suzuki K; Nishiwaki K; Yano S
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638353
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of serum proteins in multiple myeloma.
Ma TZ; Piao Z; Jin SY; Kwak YG
Exp Ther Med; 2019 Jan; 17(1):649-656. PubMed ID: 30651846
[TBL] [Abstract][Full Text] [Related]
9. For survival, the emergence of oligoclonal bands after multiple myeloma treatment is less important than achieving complete remission.
Silva LSVD; Crusoe EQ; Souza LRG; Chiattone CS; Hungria VTM
Rev Bras Hematol Hemoter; 2017; 39(4):331-336. PubMed ID: 29150105
[TBL] [Abstract][Full Text] [Related]
10. Prospective Identification of Oligoclonal/Abnormal Band of the Same Immunoglobulin Type as the Malignant Clone by Differential Location of M-Spike and Oligoclonal Band.
Vyas SG; Singh G
J Clin Med Res; 2017 Oct; 9(10):826-830. PubMed ID: 28912918
[TBL] [Abstract][Full Text] [Related]
11. Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results.
Singh G
J Clin Med Res; 2017 Aug; 9(8):671-679. PubMed ID: 28725315
[TBL] [Abstract][Full Text] [Related]
12. Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.
Schmitz MF; Otten HG; Franssen LE; van Dorp S; Strooisma T; Lokhorst HM; van de Donk NW
Haematologica; 2014 Dec; 99(12):1846-53. PubMed ID: 25193963
[TBL] [Abstract][Full Text] [Related]
13. Abnormal protein bands in patients with multiple myeloma after haematopoietic stem cell transplantation: does it have a prognostic significance?
Sucak G; Suyanı E; Özkurt ZN; Yeğin ZA; Aki Z; Yagci M
Hematol Oncol; 2010 Dec; 28(4):180-4. PubMed ID: 20155734
[TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
[TBL] [Abstract][Full Text] [Related]
15. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of abnormal protein bands in multiple myeloma treated with bortezomib-based induction regimen and autologous stem cell transplantation].
Wang HH; Li J; Liu JR; Zheng D; Gu JL; Yan MS; Zou WY; Xu DR
Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):327-31. PubMed ID: 23668206
[TBL] [Abstract][Full Text] [Related]
17. Isotype class switching after transplantation in multiple myeloma.
Maisnar V; Tichý M; Smolej L; Zák P; Radocha J; Palicka V; Malý J; Bláha V
Neoplasma; 2007; 54(3):225-8. PubMed ID: 17447854
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of the appearance of abnormal protein band in patients with multiple myeloma.
Jo JC; Yoon DH; Kim S; Lee K; Kang EH; Jang S; Park CJ; Chi HS; Huh J; Park CS; Suh C
Ann Hematol; 2014 Mar; 93(3):463-9. PubMed ID: 23999647
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
